125 related articles for article (PubMed ID: 9202370)
1. Serum levels of soluble form of Fas molecule in patients with congestive heart failure.
Okuyama M; Yamaguchi S; Nozaki N; Yamaoka M; Shirakabe M; Tomoike H
Am J Cardiol; 1997 Jun; 79(12):1698-701. PubMed ID: 9202370
[TBL] [Abstract][Full Text] [Related]
2. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
Nozaki N; Yamaguchi S; Shirakabe M; Nakamura H; Tomoike H
Jpn Circ J; 1997 Aug; 61(8):657-64. PubMed ID: 9276770
[TBL] [Abstract][Full Text] [Related]
3. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
Nishigaki K; Minatoguchi S; Seishima M; Asano K; Noda T; Yasuda N; Sano H; Kumada H; Takemura M; Noma A; Tanaka T; Watanabe S; Fujiwara H
J Am Coll Cardiol; 1997 May; 29(6):1214-20. PubMed ID: 9137215
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
5. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT
Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657
[TBL] [Abstract][Full Text] [Related]
7. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
Nowak J; Rozentryt P; Szewczyk M; Gierlotka M; Duszańska A; Szyguła B; Wojnicz R; Hawranek M; Poloński L; Zembala M
Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
[TBL] [Abstract][Full Text] [Related]
9. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system.
Setsuta K; Seino Y; Ogawa T; Ohtsuka T; Seimiya K; Takano T
Circ J; 2004 Aug; 68(8):747-50. PubMed ID: 15277733
[TBL] [Abstract][Full Text] [Related]
10. Soluble antiapoptotic molecules and immune activation in chronic heart failure and unstable angina pectoris.
Fiorina P; Astorri E; Albertini R; Secchi A; Mello A; Lanfredini M; Craveri A; Olivetti G; Quaini F
J Clin Immunol; 2000 Mar; 20(2):101-6. PubMed ID: 10821461
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension.
Testa M; Yeh M; Lee P; Fanelli R; Loperfido F; Berman JW; LeJemtel TH
J Am Coll Cardiol; 1996 Oct; 28(4):964-71. PubMed ID: 8837575
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokines, soluble Fas receptor, nitric oxide and angiotensin converting enzyme in congestive heart failure.
El Sherif WT; El Tooney LF; Meki AR; Abdel Moneim A
Egypt J Immunol; 2005; 12(1):39-48. PubMed ID: 16734138
[TBL] [Abstract][Full Text] [Related]
13. Transient rise in serum soluble Fas (APO-1/CD95) in patients undergoing cardiac surgery.
Kawahito K; Misawa Y; Fuse K
Artif Organs; 2000 Aug; 24(8):628-31. PubMed ID: 10971250
[TBL] [Abstract][Full Text] [Related]
14. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha.
Comini L; Bachetti T; Agnoletti L; Gaia G; Curello S; Milanesi B; Volterrani M; Parrinello G; Ceconi C; Giordano A; Corti A; Ferrari R
Eur Heart J; 1999 Oct; 20(20):1503-13. PubMed ID: 10493849
[TBL] [Abstract][Full Text] [Related]
15. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD.
Yasuda N; Gotoh K; Minatoguchi S; Asano K; Nishigaki K; Nomura M; Ohno A; Watanabe M; Sano H; Kumada H; Sawa T; Fujiwara H
Respir Med; 1998 Aug; 92(8):993-9. PubMed ID: 9893764
[TBL] [Abstract][Full Text] [Related]
16. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system.
Filippatos GS; Tsilias K; Venetsanou K; Karambinos E; Manolatos D; Kranidis A; Antonellis J; Kardaras F; Anthopoulos L; Baltopoulos G
Int J Cardiol; 2000; 76(2-3):117-22. PubMed ID: 11104865
[TBL] [Abstract][Full Text] [Related]
17. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers.
Toyozaki T; Hiroe M; Saito T; Iijima Y; Takano H; Hiroshima K; Kohno H; Ishiyama S; Marumo F; Masuda Y; Ohwada H
Am J Cardiol; 1998 Mar; 81(6):798-800. PubMed ID: 9527100
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
Nozaki N; Yamaguchi S; Yamaoka M; Okuyama M; Nakamura H; Tomoike H
J Mol Cell Cardiol; 1998 Oct; 30(10):2003-12. PubMed ID: 9799654
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Astragalus injection on plasma levels of apoptosis-related factors in aged patients with chronic heart failure].
Zhang JG; Yang N; He H; Wei GH; Gao DS; Wang XL; Wang XZ; Song GY
Chin J Integr Med; 2005 Sep; 11(3):187-90. PubMed ID: 16181532
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
